The data revealed HOXB5 overexpression in subsets of BL, FL, MCL, and MM while discounting significant overexpression in HL, DLBCL, precursor B-cell acute lymphoid leukemia (ALL), and T-ALL. This evidence concerns the gene HOXB5 and acute lymphoblastic leukemia.